HOME >> BIOLOGY >> NEWS
NIAID unveils bioterrorism research agenda

The National Institute of Allergy and Infectious Diseases (NIAID) today released the NIAID Counter-Bioterrorism Research Agenda for CDC Category A Agents, a document describing the Institute's accelerated research plan for the most threatening agents of bioterrorism. The agenda outlines the research NIAID will undertake to help protect civilian populations from diseases such as smallpox, anthrax and plague should they be unleashed intentionally by those who wish to do harm.

The comprehensive plan includes short-, intermediate- and long-term research goals and describes specifically how bioterrorism countermeasures will be developed for each microbe. The document also contains a copy of the Strategic Plan for Counter-Bioterrorism Research of the NIAID, which provides a general overview of the Institute's broad plans for attacking the full range of potential bioterrorism pathogens.

"Research is a vital element of bioterrorism defense," says HHS Secretary Tommy G. Thompson. "The NIAID Counter-Bioterrorism Research Agenda describes the highest priorities of an accelerated program to expand research on bioterrorism agents and to quickly develop new diagnostics, drugs and vaccines to protect the public."

The Research Agenda was developed by NIAID scientists and reviewed by an outside panel of experts from academia, industry and government in early February. The plan focuses on the Category A diseases as described by the Centers for Disease Control and Prevention (CDC): anthrax, smallpox, plague, tularemia, viral hemorrhagic fevers and botulism. Those diseases cause high death rates or serious illness, are relatively easy to spread, could cause public panic or require special steps for public health preparedness. NIAID plans to develop research plans for CDC Category B and C agents in the near future.

As the National Institutes of Health's lead institute on immunology and infectious diseases research, NIAID has made many key contribu
'"/>

Contact: Sam Perdue
sp189u@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
14-Mar-2002


Page: 1 2 3 4

Related biology news :

1. TIGR and NIAID sign $65 million microbial sequencing contract
2. NIAID takes next genome step
3. NIAID awards grant to rapidly sequence the malaria mosquito genome
4. NIAID launches major step in trial of experimental shingles vaccine
5. NIAID-Supported Scientists Discover Origin Of HIV-1
6. NIAID Scientists Discover HIV Disease-Slowing Mutation
7. NIAID Doctor Successfully Treats Longest Case Of Malaria Infection On Record
8. Pacific Northwest team unveils largest virus proteome to date
9. Pacific Northwest National Lab unveils most complete human blood-plasma proteome map to date
10. Department of Energys Office of Science unveils 20-year vision for the future of basic research
11. Ancient DNA analysis unveils mystery of historys most horribly deformed man -- The Elephant Man

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/20/2018)... ... November 20, 2018 , ... Like many large breed ... Before he was a year old, his mom, Rebecca, noticed he was slow ... examined by her veterinarian and her suspicions were confirmed: Jack had bilateral hip dysplasia, ...
(Date:11/15/2018)... ... November 15, 2018 , ... Firmex today released new research on ... over 480 investment bankers and M&A advisors worldwide to compile the third annual ... the key findings in the report. , Highlights in the 2018-19 Report:, ...
(Date:11/14/2018)... ... 14, 2018 , ... In recognition of World Diabetes Day, Diopsys is lending ... The company is reaching out to help educate patients and the healthcare community about ... vision testing for people with the disease. , The American Diabetes Association (ADA) released ...
Breaking Biology News(10 mins):
(Date:11/26/2018)... ... 26, 2018 , ... USARAD Holdings Inc., the leading US ... (Virtual Radiologic founders) among other healthcare investors exhibits at the Radiological Society of ... Chicago. The company is proud to announce a 10 year anniversary since its ...
(Date:11/15/2018)... ... November 14, 2018 , ... Hüpnos announces the ... the public. It is estimated that 90 million Americans suffer from ... partner. The resulting daytime fatigue causes extreme difficulty with concentration, focus and memory. ...
(Date:11/13/2018)... ... November 13, 2018 , ... , Park Systems, world leader in Atomic Force ... growing demand for AFM technology in China, Park Systems has decided to provide direct ... in Beijing equipped with Park AFM. , The Grand Opening of the Park Beijing ...
(Date:11/9/2018)... PHILADELPHIA (PRWEB) , ... November 08, 2018 , ... ... system integrator of custom industrial automation and IT solutions with 140 employees on ... at Automation Fair®, taking place at the Pennsylvania Convention Center on November 14 ...
Breaking Biology Technology:
Cached News: